sur SENSORION (EPA:ALSEN)
Louis J. Arcudi III appointed Chief Financial Officer of Sensorion
On October 7, 2026, Sensorion, a biotechnology company focused on hearing therapies, announced the appointment of Louis J. Arcudi III as Chief Financial Officer. Based in Boston, Arcudi succeeds Laurene Danon, who will continue to advise the company to facilitate the transition.
Arcudi brings extensive financial experience, having previously held key positions at Amolyt Pharma and Millendo Therapeutics. His expertise will be invaluable to the development of the SENS-601 treatment, currently in Phase I/II clinical trials.
Laurene Danon, in her position since 2023, has played a crucial role in fundraising, notably one of 60 million euros in 2026, strengthening Sensorion's financial position.
R. E.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de SENSORION